Cargando…

Real-World Experience with Pembrolizumab Treatment in Patients with Heavily Treated Recurrent Gynecologic Malignancies

PURPOSE: We evaluated the efficacy and safety of pembrolizumab in patients with recurrent gynecologic cancers in real-world practice. MATERIALS AND METHODS: We conducted a retrospective, single-institution study of patients with recurrent gynecologic malignancies treated with pembrolizumab. The prim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Min Chul, Moon, Yong Wha, Jung, Sang Geun, Park, Hyun, Joo, Won Duk, Song, Seung Hun, Lee, Chan, Kim, Gwangil, Kim, Kyoung Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515778/ https://www.ncbi.nlm.nih.gov/pubmed/32975058 http://dx.doi.org/10.3349/ymj.2020.61.10.844

Ejemplares similares

Rechallenge with Anti-PD-1 Inhibitors in Patients with Recurrent Gynecologic Malignancies
por: Kim, Migang, et al.
Publicado: (2023)

Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
por: Kim, Byung Wook, et al.
Publicado: (2021)

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
por: Zibetti Dal Molin, Graziela, et al.
Publicado: (2018)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

The multistep process of vaginal cancer arising from deep infiltrating endometriosis: a case report
por: Kim, Jee Hyun, et al.
Publicado: (2021)

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)

Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
por: Choi, Min Chul, et al.
Publicado: (2020)

Synchronous gynecologic malignancy and preliminary results of Lynch syndrome
por: Kim, Min Kyu, et al.
Publicado: (2011)

USP19 and RPL23 as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma
por: Kang, Haeyoun, et al.
Publicado: (2021)

Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population
por: Ahmadzada, Tamkin, et al.
Publicado: (2020)

Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer
por: Cabezas-Camarero, Santiago, et al.
Publicado: (2022)

Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers
por: Noh, Joseph J., et al.
Publicado: (2022)

Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review
por: Kim, Myeong Seon, et al.
Publicado: (2018)

Multiple Primary Malignancies in Patients with Gynecologic Cancer
por: Yang, Eun-Jung, et al.
Publicado: (2021)

Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed/Refractory Hodgkin’s Lymphoma
por: Yu, Tsung-Ying, et al.
Publicado: (2020)

Preoperative hypoalbuminemia is a risk factor for 30-day morbidity after gynecological malignancy surgery
por: Kim, Jin, et al.
Publicado: (2015)

Gynecologic malignancy in pregnancy
por: Ji, Yong Il, et al.
Publicado: (2013)

Hemorrhagic Recurrence in Diffuse Astrocytoma without Malignant Transformation
por: Baek, Hyun Joo, et al.
Publicado: (2014)

Prediction model for 30-day morbidity after gynecological malignancy surgery
por: Shim, Seung-Hyuk, et al.
Publicado: (2017)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Association between atypical endometriosis and ovarian malignancies in the real world
por: So, Kyeong A, et al.
Publicado: (2021)

Comparison of Ramosetron with Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients Receiving Opioid-Based Intravenous Patient-Controlled Analgesia after Gynecological Laparoscopy
por: Ahn, Eun Jin, et al.
Publicado: (2017)

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
por: Lee, Hee Jun, et al.
Publicado: (2013)

Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
por: Liu, Xiu, et al.
Publicado: (2023)

Pelvic exenteration for recurrent or advanced gynecologic malignancies – Analysis of outcome and complications
por: ter Glane, L., et al.
Publicado: (2021)

Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma
por: Liu, Jiayong, et al.
Publicado: (2021)

Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors
por: Hurkmans, Daan P., et al.
Publicado: (2021)

Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review
por: Cafaro, Alessandro, et al.
Publicado: (2020)

Disparities in Gynecological Malignancies
por: Chatterjee, Sudeshna, et al.
Publicado: (2016)

Pembrolizumab (and friends) in pediatric malignancies: should we consider Hodgkin lymphoma a world of its own?
por: Algeri, Mattia, et al.
Publicado: (2020)

Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines
por: Lee, Sanghoon, et al.
Publicado: (2017)

Complications Following Outside-in and Inside-out Transobturator-Tape Procedures with Concomitant Gynecologic Operations
por: Cho, Moon Kyoung, et al.
Publicado: (2011)

Heavily doped semiconductors
por: Fistul’, Victor I
Publicado: (1995)

Outcomes of surgical resection and intraoperative electron radiotherapy for patients with para-aortic recurrences of gastrointestinal and gynecologic malignancies
por: Hall, Jacob, et al.
Publicado: (2023)

Pembrolizumab for all
por: Kim, Myung S., et al.
Publicado: (2022)

Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report
por: Yun, Sook Jung, et al.
Publicado: (2020)

Distribution of lymphocele following lymphadenectomy in patients with gynecological malignancies
por: Song, Soo Youn, et al.
Publicado: (2020)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis
por: Kao, Hsiang-Fong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k01j68kmbl7r5jl5u0r8579900